Jonathan C. Javitt
Director, BRAINSTORM CELL THERAPEUTICS INC.
Companies
- NRX Pharmaceuticals, Inc.Chair Dec 18, 2024 to now1
- NRX Pharmaceuticals, Inc.Chief Scientist Jun 2, 2022 to Aug 24, 20232
- NRX Pharmaceuticals, Inc.Board member Jun 10, 2021 to Aug 24, 20233
- NRX Pharmaceuticals, Inc.Chief executive officer Jun 10, 2021 to Jun 10, 20213
- BRAINSTORM CELL THERAPEUTICS INC.Board member Aug 30, 2007 to Feb 16, 20104
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- NRX Pharmaceuticals, Inc. NRXP114,634 shares5$310.7K at $2.71Dec 18, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 17, 2024Bought 40,000 shares at $1.17 of NRX Pharmaceuticals, Inc.5
- Aug 23, 2023Bought 100,000 shares at $0.33 of NRX Pharmaceuticals, Inc.6
- Aug 22, 2023Bought 200,000 shares at $0.32 of NRX Pharmaceuticals, Inc.7
- Dec 14, 2022Gift 300,000 shares of NRX Pharmaceuticals, Inc.8
- Dec 7, 2022Sold 400,000 shares at $1.00 of NRX Pharmaceuticals, Inc.9
- Jun 1, 2022Bought 100,000 shares at $0.58 of NRX Pharmaceuticals, Inc.10
- Jun 1, 2022Bought 100,000 shares at $58.00 of NRX Pharmaceuticals, Inc.11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARNRX Pharmaceuticals, Inc., Chair
- 2
- 3
- 4
- 5
- 6SEC EDGARForm 4 filed Aug 24, 2023
- 7SEC EDGARForm 4 filed Aug 23, 2023
- 8SEC EDGARForm 5 filed Feb 14, 2023
- 9SEC EDGARForm 4 filed Dec 9, 2022
- 10SEC EDGARForm 4 filed Jun 2, 2022
- 11SEC EDGARForm 4 filed Jun 2, 2022